Blog

This Tech CEO Raised a $1M Seed Round While Treating Covid-19 patients, and Relying on Her Own Product

July 29, 2020

During the height of the Covid-19 pandemic in Philadelphia, tech entrepreneur Dr. Subha Airan-Javiaspent weeks taking care of recovering Covid-19 patients at a local long-term acute care facility. Not only did she and her fellow clinicians rely on the product she created, in-patient workflow management app TrekIT Health, she was also busy raising a $1 […]

Read More

Biopharma Tackles COVID-19, HIV and Other Viruses with Gene and Cell Therapies

July 27, 2020

Deploying CRISPR against hidden HIV reservoirs Excision BioTherapeutics is applying both CRISPR and AAV delivery toward solving a different but equally vexing problem in antiviral drug development: HIV. Even though antiretroviral drugs can tamp down the virus to the point where it’s no longer detectable in the blood, it can hide out in “reservoirs” and […]

Read More

Bainbridge Health Is Harnessing Medication Utilization Data to Conserve Waste and Manage The Supply of Critical Care Drugs Used to Treat COVID-19 Patients

July 27, 2020

Since the beginning of the pandemic, Bainbridge Health has been closely monitoring network data to identify trends in the utilization of neuromuscular blockers, vasoactive agents, and sedatives. Through the analysis of smart infusion pump data and drug preparation data, the company has been assisting its network hospitals in surfacing drug waste and determining optimal formulations […]

Read More

Pennsylvania Tech Steps Up in COVID-19 Recovery Efforts

July 24, 2020

Earlier this year when the COVID-19 pandemic halted operations of Pennsylvania and the entire world, we found ourselves in the position of balancing public health and safety with economic and community recovery efforts. We know that personal protective equipment, including masks, face shields, and hand sanitizer help us prevent the spread of coronavirus, but until […]

Read More

Can an Animal Vaccine Developer be the One to Tame Covid-19? MBF Therapeutics Places its Bet

July 23, 2020

MBF Therapeutics, which to date has focused on developing DNA-based vaccines for animals, said Thursday it has formed a collaboration with four life science industry partners to work on a Covid-19 vaccine for humans. The collaboration with MRIGlobal, Rymedi, SSI Strategy and Aldevron will seek to advance MBF Therapeutics’ SARS CoV-2 vaccine candidate COVE-001. Financial […]

Read More

Previous Next